Senior insider sale
General Counsel at UROGEN PHARMA LTD. — senior position signals high conviction
$142.5K
7.52K shares
What this filing means
SMITH JASON DREW plans to sell 7.52K shares of UROGEN PHARMA LTD. valued at approximately $142.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/29/2025ACC: 0001976408-25-000248
Officer· General Counsel
Since Aug 2020
7.52K
Shares to sell
$142.5K
Approx. market value
16.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/31/2024
16.50KTotal acquired16.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2024 | Restricted Stock Units N/A | 16.50K | — |
| Total | 16.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.52K
Market value
$142.5K
7/28/2025
Total
Units
7.52K
Value
$142.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/28/2025 | 7.52K | $142.5K | NASDAQ | Planned |
| Total | 7.52K | $142.5K | ||